SAFETY-A + CLASP for Youth Suicide Prevention
(YPIC-SP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which approach is more effective for young people experiencing suicidal thoughts or behaviors: a combined method using SAFETY-A and CLASP follow-up contacts, or SAFETY-A with standard emergency care. SAFETY-A focuses on safety planning and stabilization, while CLASP provides ongoing support after hospital discharge. Teens and young adults aged 13-24 who have experienced suicidal thoughts or plans in the past week may be suitable for this study. The researchers aim to assess how these treatments help over time, with evaluations at 3, 6, and 12 months. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to significant mental health advancements.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the SAFETY-A program, formerly known as the Family Intervention for Suicide Prevention (FISP), is safe for young people. Studies indicate it reduces suicidal thoughts and actions without major side effects. The program focuses on creating a safety plan and providing stability during emergency room visits.
For the combined treatment, which includes SAFETY-A and the CLASP (Coping Long Term with Active Suicidality Program) follow-up, research also suggests safety. Early results show it helps manage suicidal behavior. The CLASP program includes brief follow-up calls to support participants, which have proven effective without serious negative effects.
Both treatments aim to offer extra care and support to help young people in crisis, and existing studies suggest they are safe and helpful.12345Why are researchers excited about this trial?
Researchers are excited about the SAFETY-A and CLASP approach because it offers a fresh take on youth suicide prevention by integrating therapeutic follow-up with emergency department care. Unlike standard treatments that often end at the hospital, this method includes ongoing support through the Coping Long Term with Active Suicidality Program (CLASP). This continuous engagement aims to provide stability and support, addressing gaps in care after an initial crisis. Additionally, SAFETY-A integrates safety planning into emergency care, potentially improving immediate stabilization and family involvement. These features could lead to more comprehensive and effective prevention strategies compared to traditional, short-term interventions.
What evidence suggests that this trial's treatments could be effective for youth suicide prevention?
Research has shown that the SAFETY-A method, used in emergency care, can reduce the risk of future suicidal thoughts and actions in young people. Studies found it led to fewer repeat visits to the emergency room and less self-harm. In this trial, one group of participants will receive SAFETY-A integrated within usual ED care. Another group will receive a combined approach that includes both SAFETY-A and the CLASP program, which adds follow-up support with therapy and case management. The CLASP program has also reduced suicidal behaviors. When combined with SAFETY-A, this approach improves mental health and safety over time. Together, these treatments have led to better outcomes for many young people dealing with suicidal thoughts.36789
Who Is on the Research Team?
Joan R Asarnow, PhD
Principal Investigator
University of California, Los Angeles
David Goldston, PhD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for young people aged 15-24 who have recently experienced suicidal thoughts or behaviors. They must be able to give informed consent and engage in the study, which means they can't have conditions like active psychosis or drug dependence that would interfere. Participants and their parents must speak English fluently, with parents also having the option of Spanish.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive SAFETY-A integrated within usual ED Care, with or without additional therapeutic follow-up contacts using the CLASP model
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 3, 6, and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
- SAFETY-A within usual ED Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Duke University
Collaborator
Brown University
Collaborator
Olive View-UCLA Education & Research Institute
Collaborator
RAND
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator
University of Utah
Collaborator